Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
McGrath, Patrick J.
Quitkin, Frederic M.
and
Klein, Donald F.
1995.
Bromocriptine Treatment of Relapses Seen During Selective Serotonin Re-uptake Inhibitor Treatment of Depression.
Journal of Clinical Psychopharmacology,
Vol. 15,
Issue. 4,
p.
289.
Al-Adwani, A.
1995.
Brain damage and tardive dyskinesia.
British Journal of Psychiatry,
Vol. 167,
Issue. 3,
p.
410.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 4,
p.
690.
Fitzgerald, K.
and
Healy, D.
1995.
Dystonias and dyskinesias of the jaw associated with the use of SSRIs.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. 3,
p.
215.
1995.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 29,
Issue. 3,
p.
516.
Devane, C. Lindsay
1995.
Comparative safety and tolerability of selective serotonin reuptake inhibitors.
Human Psychopharmacology: Clinical and Experimental,
Vol. 10,
Issue. S3,
p.
S185.
1996.
Psychopathology in women with HIV disease and drug abuse.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
448.
1996.
Tardive dyskinesia associated with fluoxetine.
Psychiatric Services,
Vol. 47,
Issue. 9,
p.
991.
Armitage, Roseanne
1996.
Effects of Antidepressant Treatment on Sleep EEG in Depression.
Journal of Psychopharmacology,
Vol. 10,
Issue. 1_suppl,
p.
22.
Jellinger, Kurt A.
1996.
Handbuch der Gerontopsychiatrie.
p.
202.
KESHAVAN, MATCHERI S.
and
AGUILAR, EDUARDO J.
1996.
Drs. Keshavan and Aguilar Reply.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
448.
Basson, Rosemary
1996.
Sexuality and parkinson's disease.
Parkinsonism & Related Disorders,
Vol. 2,
Issue. 4,
p.
177.
1996.
Fluoxetine and extrapyramidal side effects.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
449a.
Thomas, P
Roche, J
Maron, M
Cotencin, O
Vaiva, G
and
Goudemand, M
1996.
Severe extrapyramidal symptoms with fluvoxamine despite neuroleptics withdrawal.
European Psychiatry,
Vol. 11,
Issue. 5,
p.
273.
Tiihonen, J.
Kuoppamäki, M.
Syvälahti, E.
Någren, K.
Eronen, E.
Hietala, J.
and
Bergman, J.
1996.
Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.
Psychopharmacology,
Vol. 126,
Issue. 4,
p.
277.
1996.
Alternative diagnostic procedures.
American Journal of Psychiatry,
Vol. 153,
Issue. 3,
p.
449b.
Vandel, P.
Bonin, B.
Vandel, S.
Sechter, D.
and
Bizouard, P.
1996.
CYP 2D6 PM phenotype hypothesis of antidepressant extrapyramidal side-effects.
Medical Hypotheses,
Vol. 47,
Issue. 6,
p.
439.
Salokangas, R. K. R.
Saarijärvi, S.
Taiminen, T.
Kallioniemi, H.
Lehto, H.
Niemi, H.
Tuominen, J.
Ahola, V.
and
Syvälahti, E.
1996.
Citalopram as an adjuvant in chronic schizophrenia: a double‐blind placebo‐controlled study.
Acta Psychiatrica Scandinavica,
Vol. 94,
Issue. 3,
p.
175.
1996.
Help seeking by immigrant Indochinese psychiatric patients in Sydney, Australia.
Psychiatric Services,
Vol. 47,
Issue. 9,
p.
993.
1997.
Correspondence.
Australian & New Zealand Journal of Psychiatry,
Vol. 31,
Issue. 5,
p.
772.
eLetters
No eLetters have been published for this article.